A DESCRIPTIVE EPIDEMIOLOGICAL STUDY ON MIGRAINE
Objective: The main objective was to carry out the observational study in migraine patients.
Methods: A prospective observational study was conducted for 6 months in 415 migraine patients with the prior approval from the Institutional Ethical committee. A predesigned pro forma was used to collect data such as socio-demographics of the patients, different types of migraine, triggering factors, and prescription pattern.
Results: Among 415 patients, the female patients (n=356, 86%) outnumbered male patients (n=95, 14%). The mean age of the study population was found to be 59±54 years. In our study, we found that migraine without aura (79%) was most common, followed by probable migraine without aura (13.3%), chronic migraines (5%), and migraine with aura (0.3%). Grading is done according to International Headache Society into 0, mild, moderate, and severe.
Conclusion: Compared to migraine with aura, migraine without aura is mostly seen in females than males due to fluctuating hormone levels, rural area is most effected due to exposure to triggers. Management includes pharmacological and non-pharmacological. Pharmacological therapy included nonsteroidal anti-inflammatory drugs agents, Triptans, and prophylactic therapy, and adjunctive therapy also prescribed.
2. Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 2018;38:1-211.
3. Poojitha M, Sharanya M, Deepthi E, Prasad OP, Sunder AS. A review on migraine Acta Sci Pharm Sci 2019;3:29-42.
4. Teixido M, Carey J. Migraine-more than a headache. Otolaryngol Head Neck Surg 2014;14:1-4.
5. Yadav RK, Kalita J, Misra UK. A study of triggers of migraine in India. Pain Med 2010;11:44-7.
6. Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD. The prevalence of premonitory symptoms in migraine: A questionnaire study in 461 Patients. Cephalalgia 2006;26:1209-13.
7. Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache 2018;58 Suppl 1:4-16.
8. Nyholt DR, Gillespie NG, Heath AC, Merikangas KR, Duffy DL, Martin NG. Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet Epidemiol 2004;26:231-44.
9. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354-61.
10. Galletti F, Cupini LM, Corbelli I, Calabresi P, Sarchielli P. Pathophysiological basis of migraine prophylaxis. Prog Neurobiol 2009;89:176-92.
11. Elrington G. Migraine: Diagnosis and management. J Neurol Neurosurg Psychiatry 2002;72 Suppl 2:ii10-5.
12. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: A population study. Neurology 2006;66:545-50.
13. Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, et al. Migraine headache is present in the aura phase: A prospective study. Neurology 2012;79:2044-9.
14. Giffin NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ. The migraine postdrome: An electronic diary study. Neurology 2016;87:309-13.
15. Terrin A, Toldo G, Ermani M, Mainardi F, Maggioni F. When migraine mimics stroke: A systematic review. Cephalalgia 2018;38:2068-78.
16. Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and Ménière’s disease: Is there a link? Neurology 2002;59:1700-4.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.